Accessibility Menu
Eve Health Group logo

Eve Health Group(ASX) EVE

Market CapA$5.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-96%
5 Year-92%
1 Year-54%
1 Month-16%
A$0.02
-5.88%
-0.00Today
Eve Health Group last closing stock price
MetricPriceDate
Last closeAUD 0.022026-07-31
Eve Health Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-5.88%AUD 0.022026-07-23
1 month-15.79%AUD 0.022026-07-01
3 month-44.83%AUD 0.032026-05-01
Year to date-23.81%AUD 0.022025-12-30
1 year-54.29%AUD 0.042025-07-31
3 year-60%AUD 0.042023-07-31
5 year-92%AUD 0.202021-07-30
Since inception-96.38%AUD 0.442004-04-08

Eve Health Group Financials at a Glance

Market Cap

A$5.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$3.37M

Net Income (TTM)

-A$3.38M

EPS (TTM)

-A$0.01

P/E Ratio

-1.74

Dividend

A$0.00

Beta (Volatility)

0.32 (Low)

Price

A$0.02

Volume

0

Open

A$0.02

Previous Close

A$0.02

Daily Range

A$0.02 - A$0.02

52-Week Range

A$0.02 - A$0.04

Estimated Earnings Date

Feb 26, 2026

EVE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Eve Health Group

EVE Health Group Limited is an international provider of health, wellness, and nutritional products, based in Subiaco, Australia. The company specializes in organic tea tree oils, botanical oils, and medical nutrition solutions, operating across Australia, New Zealand, the Asia Pacific region, and North America.

Products and Services
  • Organic tea tree oils and botanical oils
  • Medical nutrition solutions for chronic ailments
  • Contract manufacturing services for various health products
Growth Outlook
  • Expansion into North American markets is underway
  • Focus on developing innovative medical nutrition products
  • Increased demand for organic and natural health products
Financial Highlights
  • Recent quarterly revenue of AUD 632,874, showing potential for growth
  • Cash and cash equivalents of AUD 929,659, providing liquidity
  • Current ratio of 3.48 indicates strong short-term financial health
EVE Health Group Limited has positioned itself in a growing industry, focusing on health and wellness products that cater to increasing consumer demand for organic and natural solutions. The company's diverse product offerings, including organic tea tree oils and medical nutrition solutions, align with current market trends favoring health-conscious choices. Recent financial data indicates a revenue of AUD 632,874 for the latest quarter, reflecting the company's ability to generate income despite challenges. The current ratio of 3.48 suggests that EVE Health Group is well-equipped to meet its short-term obligations, which is a positive indicator for potential investors. With ongoing efforts to expand into North American markets and a commitment to innovation in medical nutrition, EVE Health Group Limited presents an intriguing opportunity for those interested in the health and wellness sector. The company's focus on organic products and its strategic growth initiatives may position it favorably in a competitive landscape.
AI Generated • Jul 19, 2026

Industry

Food Products

CEO

Gregory William Fry

Headquarters

Subiaco, WA 6008, AU

EVE Financials

Key Financial Metrics (TTM)

Gross Margin

28.29%

Operating Margin

-107.40%

Net Income Margin

-119.12%

Return on Equity

-44.35%

Return on Capital

-39.20%

Return on Assets

-39.87%

Earnings Yield

-57.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$5.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

352.33M

Volume

0

Avg. Volume

335.72K

Financials (TTM)

Gross Profit

A$966.48K

Operating Income

-A$2.69M

EBITDA

-A$2.99M

Operating Cash Flow

-A$3.05M

Capital Expenditure

-A$1.89K

Free Cash Flow

-A$3.05M

Cash & ST Invst.

A$929.66K

Total Debt

A$38.51K

Eve Health Group Performance Analysis

Eve Health Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 2,009,195N/A
20232023-06-30AUD 2,330,65816.0%
20242024-06-30AUD 2,133,771-8.4%
20252025-06-30AUD 1,734,726-18.7%
Eve Health Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30-12.1%
Q22024-12-310.8%
Q42025-06-30-27.6%
Q22025-12-31-13.1%
Eve Health Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.05N/A
20232023-06-30AUD -0.03-42.5%
20242024-06-30AUD -0.01-53.2%
20252025-06-30AUD -0.01-20.1%
Eve Health Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q22024-12-3150.0%
Q42025-06-30-5400.0%
Q22025-12-3141.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$632.87K

-44.3%

Gross Profit

A$42.23K

-90.8%

Gross Margin

6.67%

N/A

Market Cap

A$5.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$1.76M

N/A

Employees

3

N/A

Net Income

-A$848.47K

+10.6%

EBITDA

-A$851.14K

-3.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$929.66K

+729.6%

Total Debt

A$38.51K

-88.6%

Accounts Receivable

A$40.36K

-11.9%

Inventory

A$100.11K

-68.8%

Long Term Debt

A$0.00

N/A

Short Term Debt

A$38.51K

-88.6%

Return on Assets

-39.87%

N/A

Return on Invested Capital

-38.89%

N/A

Free Cash Flow

-A$909.83K

-55.9%

Operating Cash Flow

-A$907.94K

-55.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ERG.AXEneco Refresh Limited
A$0.02+0.00%
8IH.AX8I Holdings Limited
A$0.01+0.00%
SKN.AXSkin Elements Limited
A$0.01+0.00%
WNX.AXWellnex Life Limited
A$0.06+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About EVE

What is the current price of Eve Health Group?

Eve Health Group is trading at A$0.02 per share.

What is the 52-week range for Eve Health Group?

Over the past 52 weeks, Eve Health Group has traded between A$0.02 and A$0.04.

How much debt does Eve Health Group have?

As of the most recent reporting period, Eve Health Group reported total debt of A$91.29K.

How much cash does Eve Health Group have on hand?

Eve Health Group reported A$903.42K in cash and cash equivalents in its most recent financial results.

What is Eve Health Group’s dividend yield?

Eve Health Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.